Brief: Solasia Pharma says termination of clinical trials phase 1 of SP-04

Solasia Pharma KK

09/02/2018 08:12

Feb 9 (Reuters) - Solasia Pharma KK  4597.T   
     
    * Says it announces termination of SP-04 clinical trials 
phase 1, 
for treatment of peripheral nerves disability  
 
     
    Source text in Japanese:https://goo.gl/inouVL 
    Further company coverage: 4597.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111; 
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))